Stock Earnings

Question 1

What are Galectin Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Galectin Therapeutics Inc has a total asset of $17, Net loss of $-47

Question 2

What are the key financial ratios for GALT?

Accepted Answer

Galectin Therapeutics Inc's Current ratio is 0.14, has a Net margin is 0, sales per share of $0.

Question 3

How is Galectin Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Galectin Therapeutics Inc data is not available.

Question 4

Is Galectin Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Galectin Therapeutics Inc has a net loss of $-47

Question 5

Does Galectin Therapeutics Inc have any liabilities?

Accepted Answer

yes, Galectin Therapeutics Inc has liability of 120

Question 6

How many outstanding shares for Galectin Therapeutics Inc?

Accepted Answer

Galectin Therapeutics Inc has a total outstanding shares of 63.15

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	5	5	5	6	6	5
Research & Development	23	36	32	31	23	17
Operating Expenses	29	42	38	38	30	23
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-37	-47	-41	-38	-30	-23
Income Tax Expense	--	--	--	--	--	--
Net Income	-37	-47	-44	-38	-30	-23
Net Income Growth	-18%	7%	16%	27%	30%	15%
Shares Outstanding (Diluted)	64.2	62.3	60.15	59.39	58.53	57.03
Shares Change (YoY)	3%	4%	1%	1%	3%	9%
EPS (Diluted)	-0.59	-0.75	-0.74	-0.65	-0.52	-0.41
EPS Growth	-19%	2%	15%	25%	27%	5%
Free Cash Flow	-30	-41	-32	-31	-24	-20
Free Cash Flow Per Share	-0.46	-0.65	-0.53	-0.52	-0.41	-0.35
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	--	-42	-38	--	--	--
EBITDA Margin	--	0%	0%	--	--	--
D&A For EBITDA	--	0	0	--	--	--
EBIT	-29	-42	-38	-38	-30	-23
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Galectin Therapeutics Inc (GALT) Price